Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $30000.0.

  • NeuroPace's Capital Expenditures fell 7000.0% to $30000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $274000.0, marking a year-over-year decrease of 836.12%. This contributed to the annual value of $306000.0 for FY2024, which is 7687.86% up from last year.
  • NeuroPace's Capital Expenditures amounted to $30000.0 in Q3 2025, which was down 7000.0% from $64000.0 recorded in Q2 2025.
  • NeuroPace's 5-year Capital Expenditures high stood at $306000.0 for Q1 2022, and its period low was $9000.0 during Q3 2023.
  • For the 5-year period, NeuroPace's Capital Expenditures averaged around $94500.0, with its median value being $82000.0 (2024).
  • As far as peak fluctuations go, NeuroPace's Capital Expenditures crashed by 8258.43% in 2022, and later surged by 101111.11% in 2024.
  • Quarter analysis of 5 years shows NeuroPace's Capital Expenditures stood at $154000.0 in 2021, then crashed by 33.77% to $102000.0 in 2022, then plummeted by 68.63% to $32000.0 in 2023, then rose by 21.88% to $39000.0 in 2024, then dropped by 23.08% to $30000.0 in 2025.
  • Its last three reported values are $30000.0 in Q3 2025, $64000.0 for Q2 2025, and $141000.0 during Q1 2025.